Inogen Inc
NASDAQ:INGN
Inogen Inc
Revenue
Inogen Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Inogen Inc
NASDAQ:INGN
|
Revenue
$315.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
23%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Inogen Inc
Revenue Breakdown
Breakdown by Geography
Inogen Inc
Total Revenue:
315.7m
USD
|
United States:
226.3m
USD
|
Non-Us:
89.4m
USD
|
Breakdown by Segments
Inogen Inc
See Also
What is Inogen Inc's Revenue?
Revenue
315.7m
USD
Based on the financial report for Dec 31, 2023, Inogen Inc's Revenue amounts to 315.7m USD.
What is Inogen Inc's Revenue growth rate?
Revenue CAGR 10Y
23%
Over the last year, the Revenue growth was -16%. The average annual Revenue growth rates for Inogen Inc have been 1% over the past three years , -2% over the past five years , and 23% over the past ten years .